UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000012375
Receipt No. R000014468
Scientific Title A Pharmacokinetic and Phase II Study of Pertuzumab in Combination With Trastuzumab And Eribulin (Halaven) in Patients With Advanced HER2-Positive Breast Cancer
Date of disclosure of the study information 2013/11/21
Last modified on 2016/06/14 10:32:51

No. Disposal Last modified on Item of update
1 Insert 2013/11/21 16:23:19
2 Update 2013/11/21 16:27:43 Organization
Organization
3 Update 2013/11/22 15:42:16 Public title
4 Update 2014/01/10 16:50:53 Recruitment status
5 Update 2015/05/22 08:13:56


6 Update 2015/07/29 20:04:16 Acronym
Acronym
7 Update 2015/07/29 20:05:12 Recruitment status
8 Update 2015/11/24 11:51:05 Recruitment status
Last follow-up date
9 Update 2016/06/14 10:32:51 Recruitment status


Contact us.